CXApp Inc.
For the period ended Dec 31, 2024. Filed Apr 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
NOTE 1 –Organization, Nature of Business and Basis of Presentation
CXApp Inc. and its subsidiaries (“CXApp” or the “Company”) is in the business of delivering intelligent enterprise employee experiences. The CXApp SaaS platform is anchored on the intersection of customer experience (CX) and artificial intelligence (AI) providing digital transformation for the physical workplace for enhanced experiences across people, places and things.
The CXApp SaaS platform offers a suite of leading-edge technology employee experience solutions including an enterprise employee application, indoor mapping, on-device positioning, augmented reality technologies, generative AI applications and an AI-based analytics platform, targeting the emerging hybrid workplace market. CXApp creates a connected workplace by reducing app overload, data fragmentation, and complex workflows and streamlines all capabilities through our platform. All features, services and integrations are housed in one easy-to-access platform allowing businesses to deliver a more holistic employee experience in a hybrid workplace.
On September 25, 2022, an Agreement and Plan of Merger (the “Merger Agreement”) was entered into by and among Inpixon, KINS, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (“Merger Sub”), pursuant to which KINS acquired Inpixon’s enterprise apps business (including its employee experience technologies, indoor mapping, events platform, augmented reality and related business solutions) (“Legacy CXApp”) in exchange for the issuance of shares of KINS capital stock (the “Business Combination”). As a result of the Business Combination, KINS changed their name to CXApp Inc. (“CXApp”). The shares are now trading on the Nasdaq using the ticker CXAI. The transaction closed on March 14, 2023. See Note 3 for more details.
Unless the context otherwise requires, “we,” “us,” “our,” “CXApp” and the “Company” refer to CXApp Inc., a Delaware corporation, and its consolidated subsidiaries following the Business Combination (as defined below). Unless the context otherwise requires, references to “KINS” refer to KINS Technology Group Inc., a Delaware corporation (“KINS”), prior to the Business Combination. All references herein to the “Board” refer to the board of directors of the Company. “Legacy CXApp” refers to CXApp Holding Corp., a Delaware corporation and a wholly owned subsidiary of the Company, which the Company acquired through the Business Combination. Prior to the Separation (as defined below), Legacy CXApp was a wholly owned subsidiary of Inpixon, a Nevada corporation (“Inpixon”).
The Business Combination was accounted for using the acquisition method (as a forward merger), with goodwill and other identifiable intangible assets recorded in accordance with GAAP, as applicable. Under this method of accounting, the “Enterprise Apps Business” (formerly known as CXApp) is treated as the “acquired” company for financial reporting purposes. KINS (now known as CXApp Inc.) has been determined to be the accounting acquirer because KINS maintains control of the Board of Directors and management of the combined company.
Restatement of Unaudited Consolidated Financial Information (Unaudited)
During the preparation of its consolidated financial statements for the year ended December 31, 2024, the Company identified an error in its previously issued unaudited consolidated financial statements for the quarter ended September 30, 2024. The error related to an under accrual of legal expenses.
During the third quarter of 2024, the Company recorded an accrual for legal expenses based on estimates available at the time. In the fourth quarter of 2024, upon receipt of the final invoice from legal counsel for services rendered throughout the year, management identified that the previously recorded accrual was understated and subsequently made an adjustment to reflect the actual amount due. As a result, the Company determined that the September 30, 2024 accrual was understated. After further review of related legal expenses and invoices, the Company recorded an adjustment to reflect and restate the correct accrual for legal fees incurred in the third of 2024.
Furthermore, during the fourth quarter of 2024, the Company identified an error in the application of U.S. GAAP in the calculation of its convertible debt liability. Specifically, the Company did not account for the embedded derivatives requiring bifurcation from the debt host liability to be accounted for at fair value under ASC 815. The Company has revised its accounting treatment at inception of the convertible debt liability to account for the instrument in its entirety under the fair value option election allowed under ASC 825. In addition, the Company did not correctly account for the commitment shares required to be issued to the lender under the Stock Purchase Agreement. The Company should have established a liability at inception of the Stock Purchase Agreement and relieved such liability in October 2024 when the shares were issued to the lender.
Accordingly, the Company has restated its previously issued unaudited consolidated financial statements as of and for the periods ended June 30, 2024 and September 30, 2024. The Company has also restated impacted amounts within the notes to the consolidated financial statements, as applicable.
The restated unaudited consolidated financial information is disclosed in Note 21, Quarterly Financial Information (Unaudited). Amounts included in the previously issued consolidated financial statements for the period March 15, 2023 to December 31, 2023 (Successor) and for period January 1, 2023 to March 14, 2023 (Predecessor) and were not impacted.
NOTE 2 –Summary of Significant Accounting Policies
Liquidity
As of December 31, 2024, the Company had a working capital deficiency of approximately $4,496 thousand and cash and cash equivalents of approximately $4,880 thousand. For the year ended December 31, 2024, the Company incurred net losses of approximately $19,408 thousand. During the year ended December 31, 2024, the Company used approximately $7,325 thousand of cash for operating activities. During 2024, the Company secured additional funding through convertible Pre-Paid Purchases under the equity line agreement, receiving net proceeds of $2.48 million, $1.0 million, and $3.0 million in June, September, and December, respectively. These financing efforts reflect the Company’s proactive approach to maintaining adequate liquidity to support operational needs and strategic growth initiatives.
The Company’s quarterly cash operating expenses are approximately $3.5 million, resulting in a cash run rate of approximately three quarters based on current liquidity and the additional financing secured. Management believes that the recent funding initiatives provide sufficient capital to address near-term operational requirements and mitigate uncertainties about the Company’s ability to continue as a going concern.
On March 26, 2025, we entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Avondale Capital, LLC (“Avondale”), pursuant to which the Company may (i) issue and sell one or more pre-paid purchase agreements, in the form substantially similar to the exhibit attached thereto (each, a “Pre-Paid Purchase”), up to an aggregate purchase amount of $20,000,000.00 (the “Commitment Amount”) for shares of our common stock, par value $0.0001 per share (the “Common Stock”), on the terms and subject to the limitations and conditions set forth in each Pre-Paid Purchase, (ii) issue and sell the initial Pre-Paid Purchase in the principal amount of $4,200,000.00 (the “Initial Pre-Paid Purchase”), and (iii) deliver 80,000 shares of Common Stock (the “Commitment Shares”) to Avondale at closing.
Under the Purchase Agreement, each Pre-Paid Purchase consists of a principal balance upon which Avondale, at its option, may require the Company to issue shares of Common Stock (“Purchase Shares”), from time to time, in satisfaction of all or part of the outstanding balance of such Pre-Paid Purchase. The Company will deliver these Purchase Shares at a per-share purchase price set forth in the Pre-Paid Purchase (the “Purchase Share Purchase Price”), subject to a defined floor price and other conditions. Each Pre-Paid Purchase is a separate instrument with its own outstanding balance and holding period.
The access to the $20,000 thousand is expected to provide sufficient capital to fund customer growth initiatives and ensure long-term sustainability.
Management remains focused on executing cost management strategies to optimize the Company’s expense structure and enhance operational efficiency. The Company is committed to expanding its customer base, introducing monetizable features, and driving recurring revenue growth in fiscal year 2025. By leveraging its current cash position, financing agreements, and strategic initiatives, management is confident in CXAI’s ability to meet its obligations and support its operations for at least the next 12 months. While there are no guarantees, the Company’s robust financing pipeline and operational strategies provide a solid foundation for long-term financial stability.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of:
| ● | the valuation of stock-based compensation; |
| ● | the valuation of warrant liabilities; |
| ● | the allowance for credit losses; |
| ● | the valuation allowance for deferred tax assets; and |
| ● | impairment of long-lived assets and goodwill. |
Basis of Presentation
The accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances have been eliminated in consolidation.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, and trade receivables. The Company’s cash is placed with high-credit-quality financial institutions, which periodically exceed federally insured limits. The Company’s cash equivalents are certificates of deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less. The Company has not realized any losses relating to its cash, cash equivalents, and trade receivables.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash, checking accounts, money market accounts, temporary investments and certificates of deposit with maturities of three months or less when purchased. As of December 31, 2024, the Company had cash equivalents of approximately $4,353 thousand of certificates of deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less. As of December 31, 2023, the Company had cash equivalents of approximately $5,584 thousand of certificates of deposit.
Accounts Receivable, net and Allowance for Credit Losses
Accounts receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure accounts receivable are not overstated due to uncollectability. Allowance for credit losses is maintained for various customers based on a variety of factors, including the length of time the receivables are past due, significant one-time events and historical experience. An additional allowance for credit losses for individual accounts is recorded when the Company becomes aware of a customer’s inability to meet its financial obligation, such as in the case of bankruptcy filings, or deterioration in such customer’s operating results or financial position. If circumstances related to a customer change, estimates of the recoverability of receivables would be further adjusted. Accounts receivable, net of allowance, totaled approximately $1.7 million and $2.0 million as of December 31, 2024 and December 31, 2023, respectively. The Company’s allowance for credit losses as of December 31, 2024 is approximately $0 thousand and $2 thousand as of for the period March 15, 2023 to December 31, 2023. Accounts receivable as of March 15, 2023 totaled $2.2 million.
Property and Equipment, net
Property and equipment are recorded at cost, less accumulated depreciation and amortization. The Company depreciates its property and equipment for financial reporting purposes using the straight-line method over the estimated useful lives of the assets, which range from 5 to 10 years. Leasehold improvements are amortized over the lesser of the useful life of the asset or the initial lease term. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized. Depreciation expense related to property and equipment is not included as part of cost of revenues, but as part of operating expenses.
Intangible Assets
Intangible assets primarily consist of developed technology, customer lists/relationships, non-compete agreements, intellectual property agreements, export licenses and trade names/trademarks. They are amortized ratably over a range of 5 to 10 years, which approximates customer attrition rate and technology obsolescence. The Company assesses the carrying value of its intangible assets for impairment annually, or more frequently if an event or other circumstances indicates that the Company may not be able to recover the carrying amount of the assets. Based on its assessments, the Company didnot incur any impairment charges for the year ended December 31, 2024 (Successor), period from March 15, 2023, to December 31, 2023 (Successor), and for the period from January 1, 2023 to March 14, 2023 (Predecessor).
Goodwill
The Company tests goodwill for potential impairment at least annually, or more frequently if an event or other circumstance indicates that the Company may not be able to recover the carrying amount of the net assets of the reporting unit. The Company has determined that the reporting unit is the entire company, due to the integration of all of the Company’s activities. In evaluating goodwill for impairment, the Company may assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that the fair value of a reporting unit is less than it carrying amount. If the Company bypasses the qualitative assessment, or if the Company concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs a quantitative impairment test by comparing the fair value of a reporting unit with its carrying amount.
The Company calculates the estimated fair value of a reporting unit using a weighting of the income and market approaches. For the income approach, the Company uses internally developed discounted cash flow models that include the following assumptions, among others: projections of revenues, expenses, and related cash flows based on assumed long-term growth rates and demand trends; expected future investments to grow new units; and estimated discount rates. For the market approach, the Company uses internal analyses based primarily on market comparables, including public company method, guideline transaction method, and market price method.
The Company bases these assumptions on its historical data and experience, third party appraisals, industry projections, micro and macro general economic condition projections, and its expectations. Based on its assessments, the Company didnot incur impairment for the year ended December 31, 2024 (Successor). The Company incurred impairment charge of $36,056 thousand for the period from March 15, 2023, to December 31, 2023 (Successor) and didnot incur impairment for the period from January 1, 2023 to March 14, 2023 (Predecessor).
Leases and Right-of-Use Assets and Liabilities
The Company determines if an arrangement is a lease at its inception. Operating lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company generally uses their incremental borrowing rate based on the information available at the lease commencement date in determining the present value of future payments, because the implicit rate of the lease is generally not known. Right-of-use assets related to the Company’s operating lease liabilities are measured at lease inception based on the initial measurement of the lease liability, plus any prepaid lease payments and less any lease incentives. The Company’s lease terms that are used in determining their operating lease liabilities at lease inception may include options to extend or terminate the leases when it is reasonably certain that the Company will exercise such options. The Company amortizes their right-of-use assets as operating lease expense generally on a straight-line basis over the lease term and classify both the lease amortization and imputed interest as operating expenses. The Company does not recognize lease assets and lease liabilities for any lease with an original lease term of less than one year.
Income Taxes
The Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in the tax rate is recognized in income or expense in the period that the change is effective. Income tax benefits are recognized when it is probable that the deduction will be sustained. A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will either expire before the Company is able to realize the benefit, or that future deductibility is uncertain.
Comprehensive Income (Loss) and Foreign Currency Translation
The Company reports comprehensive income (loss) and its components in its consolidated financial statements. Comprehensive loss consists of net loss and foreign currency translation adjustments, affecting stockholders’ equity that, under GAAP, are excluded from net loss.
Assets and liabilities related to the Company’s foreign operations are calculated using the Philippine Peso and Canadian Dollar and are translated at end-of-period exchange rates, while the related revenues and expenses are translated at average exchange rates prevailing during the period. Gains or losses resulting from transactions denominated in foreign currencies are included in other income (expense) in the consolidated statements of operations. The Company engages in foreign currency denominated transactions with customers that operate in functional currencies other than the U.S. dollar. Aggregate foreign currency net translation gain or loss were approximately $301 thousand gain, $85 thousand loss, and $28 thousand loss for the year ended December 31, 2024 (Successor), for the period from March 15, 2023, to December 31, 2023 (Successor), and the period from January 1, 2023 to March 14, 2023 (Predecessor), respectively.
Convertible Debt
The Company issued convertible debt in the form of Pre-Paid Purchases in May 2024 (settlement date June 2024), September 2024, and December 2024 and evaluated such instruments to determine whether they contain features that qualify as embedded derivatives in accordance with ASC 815. Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract and the features of the derivatives. In accounting for the issuance of the convertible debt, the Company elected the fair value option under ASC 825. Under the fair value option election, the convertible debt is initially measured at its issuance date estimated fair value and subsequently remeasured at estimated fair value on a recurring basis. The estimated fair value adjustment is presented within change in fair value of derivative liability in the Consolidated Statements of Operations and Comprehensive Income (Loss). The Company classifies its convertible debt that are being valued under the fair value option election as Level 3 due to the lack of relevant observable market data over fair value inputs, such as the probability weighting of the various scenarios that can impact settlement of the arrangement. The Company recognized a gain on the changes in the estimated fair value of the convertible debt of approximately $213 thousand for the year ended December 31, 2024 (Successor).
Debt Issuance Cost
Under the fair value option election, costs directly associated with the borrowing are expensed as incurred.
Debt Extinguishment
The note exchanges are accounted for under ASC 470-50 on Modifications and Extinguishments. This standard requires the recognition of a gain or loss on the difference between the reacquisition price and the net carrying amount of the extinguished debt.
Revenue Recognition
The Company recognizes revenue, in accordance with ASC 606, when control is transferred of the promised products or services to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from its software as a service for cloud-based software, as well as design, implementation and other professional services for work performed in conjunction with its cloud-based software, and sale of hardware. The Company enters into contracts with its customers whereby it grants a non-exclusive cloud-based license for the use of its proprietary software and for professional services. The contracts may also provide for on-going services for a specified price, which may include maintenance services, designated support, and enhancements, upgrades and improvements to the software, depending on the contract. Licenses for cloud software provide the customer with a right to use the software as it exists when made available to the customer. All software provides customers with the same functionality and differs mainly in the duration over which the customer benefits from the software.
CXApp has done an analysis of its revenue recognition process and found that the same steps taken by the Company agrees with ASC 606 – Revenue from Contracts with Customers. The standard’s core principle is that an entity will recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. The new standard is a principles-based standard intended to better match the accounting for the transaction with the economics of the transaction. This requires entities to use more judgment and make more estimates than under previous revenue standards.
The standard introduces a five-step model for revenue recognition that replaces the four criteria for revenue recognition under previous GAAP. The five steps are shown below:
| 1. | Identify the contract with a customer; |
| 2. | Identify the performance obligations in the contract; |
| 3. | Determine the transaction price; |
| 4. | Allocate the transaction price to performance obligations; and |
| 5. | Recognize revenue when (or as) the entity satisfies a performance obligation |
License Subscription Revenue Recognition (Software As A Service)
With respect to sales of the Company’s license agreements, customers generally pay fixed annual fees in advance in exchange for the Company’s software service provided via electronic means, which are generally recognized ratably over the license term. Some agreements allow the customer to terminate their subscription contracts before the end of the applicable term, and in such cases the customer is generally entitled to a refund pro-rata but only for the elapsed time remaining at the point of termination, which would approximate the deferred revenue at such time. The Company’s performance obligation is satisfied over time as the electronic services are provided continuously throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous access to its service. The Company’s customers generally pay within 30 to 60 days from the receipt of a customer approved invoice.
The timing of the Company’s revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement entered into represents a service. Software that relies on an entity’s IP and is delivered only through a hosting arrangement, where the customer cannot take possession of the software, is a service. Customers may purchase perpetual licenses or subscribe to licenses, which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software.
Renewals or extensions of licenses are evaluated as distinct licenses and revenue attributed to the distinct service is not recognized until: (1) the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. The Company recognizes revenue resulting from renewal of licensed software over time.
Professional Services Revenue Recognition
The Company provides integration and software customization professional services to its customers.
Professional services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract can be estimated reliably, contract revenue is recognized in the statement of operations in proportion to the stage of completion of the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract, are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract.
Professional services are also contracted on the fixed fee and in some cases on a time and materials basis. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company’s time and materials contracts are paid weekly or monthly based on hours worked. Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize revenue for the right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date. For fixed fee contracts provided by in house personnel, the Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous service. Because the Company’s contracts have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. Anticipated losses are recognized as soon as they become known. For the year ended December 31, 2024 (Successor), for period from March 14, 2024, to December 31, 2023 (Successor) and for the period from January 1, 2023 to March 14, 2023 (Predecessor), the Company did not incur any such losses. These amounts are based on known and estimated factors.
Hardware Revenue Recognition
For sales of hardware, the Company’s performance obligation is fulfilled when the products are shipped to the customer, transferring title and ownership risks. Deliveries occur via drop-shipment by a third-party vendor and the Company leverages drop-ship arrangements with many of its vendors and suppliers to deliver products to customers without having to physically hold the inventory at its warehouse. The Company negotiates sale prices, pays suppliers directly, manages credit risk, and ensures product acceptability, acting as the principal in the transaction and recording revenue on a gross basis. Customers typically pay within 30 to 60 days of invoice receipt. The Company has elected the practical expedient to expense the costs of obtaining a contract when they are incurred because the amortization period of the asset that otherwise would have been recognized is less than a year.
Contract Balances
The timing of the Company’s revenue recognition may differ from the timing of invoicing to and payment by its customers. The Company records an unbilled receivable when revenue is recognized prior to invoicing and the Company has an unconditional right to payment. Alternatively, when invoicing a customer precedes the Company providing of the related services, the Company records deferred revenue until the performance obligations are satisfied. The Company had deferred revenue of approximately $2,683 thousand and $2,878 thousand as of December 31, 2024, and December 31, 2023, respectively, related to customer invoices rendered in advance for software licenses and professional services provided by the Company’s technical staff. The Company expects to satisfy its remaining performance obligations for the deferred revenue associated with professional services, and recognize the deferred revenue related to licenses generally over the remaining contract term which is generally twelve months following the commencement of the license. The Company recognized revenue in the reporting period of $2,606 thousand, $2,163 thousand, and $865 thousand, that was included in the deferred revenue at the beginning of the period, for the year ended December 31, 2024 (Successor), for the period from March 15, 2023 to December 31, 2023 (Successor), and for the period from January 1, 2023 to March 14, 2023 (Predecessor), respectively.
Costs to Obtain a Contract
The Company recognizes eligible sales commissions as an asset within prepaid expenses and other current assets as the commissions are an incremental cost of obtaining a contract with the customer and the Company expects to recover these costs. The capitalized costs are amortized over the expected contract term.
Cost to Fulfill a Contract
The Company incurs costs to fulfill their obligations under a contract once it has obtained the contract. These costs are generally not significant and are recorded to expense as incurred.
Multiple Performance Obligations
The Company enters into contracts with customers for its technology that include multiple performance obligations. Each distinct performance obligation was determined by whether the customer could benefit from the good or service on its own or together with readily available resources. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company’s process for determining standalone selling price considers multiple factors including the Company’s internal pricing model and market trends that may vary depending upon the facts and circumstances related to each performance obligation.
Sales and Use Taxes
The Company presents transactional taxes such as sales and use tax collected from customers and remitted to government authorities on a net basis.
Shipping and Handling Costs
Shipping and handling costs are expensed as incurred as part of cost of revenues. These costs were deemed to be de minimis during each of the reporting periods.
Research and Development
Research and development (“R&D”) costs are expensed when incurred. R&D expenses consist primarily of personnel and related headcount costs, costs of professional services associated with the ongoing development of the Company’s technology, and allocated overhead.
Business Combinations
The Company accounts for business combinations under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 “Business Combinations” using the acquisition method of accounting, and accordingly, the assets and liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Upon acquisition, the accounts and results of operations are included as of and subsequent to the acquisition date.
Segments
The Company and its Chief Executive Officer (“CEO”), acting as the Chief Operating Decision Maker (“CODM”) determines its reporting units in accordance with FASB ASC 280, “Segment Reporting” (“ASC 280”). The Company evaluates a reporting unit by first identifying its operating segments under ASC 280. The Company then evaluates each operating segment to determine if it includes one or more components that constitute a business. If there are components within an operating segment that meet the definition of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable, when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically similar and, if so, the operating segments are aggregated. The Company has one operating segment and reporting unit. The Company is organized and operated as one business. Management reviews its business as a single operating segment, using financial and other information rendered meaningful only by the fact that such information is presented and reviewed in the aggregate.
Stock-Based Compensation
The Company measures the cost of employee and non-employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. The Company has issued stock-based compensation awards in the form of options and restricted stock units. The grant date fair value is recognized over the requisite service period during which an employee and non-employee is required to provide service in exchange for the award.
The grant date fair value of options is estimated using the Black-Scholes option pricing model based on the average of the high and low stock prices at the grant date for awards under the CXApp Inc. 2023 Equity Incentive Plan (the “Incentive Plan”). The risk-free interest rate assumptions were based upon the observed interest rates appropriate for the expected term of the equity instruments. The expected dividend yield is assumed to be zero as the Company has not paid any dividends since its inception and does not anticipate paying dividends in the foreseeable future. The Company uses the simplified method to estimate the expected term.
The grant date fair value for restricted stock units is valued using the closing price of the Company’s common stock on the date of grant.
The Company estimates forfeitures at the time of grant and revises these estimates in subsequent periods if actual forfeitures differ from those estimates.
Derivative Warrant Liabilities
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company currently has two sets of warrants outstanding, known as the Private Placement Warrants and the Public Warrants, which are both classified as a liability.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance or modification. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance as a warrant liability and adjusted to the then fair value in each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations and amounted to approximately $3,365 thousand of a loss for the year ended December 31, 2024 (Successor) and $4,714 thousand of a loss for the period from March 15, 2023, to December 31, 2023 (Successor). The Company utilized the Public Warrant quoted market price as the fair value of the Warrants as of each relevant date.
Earnings Per Share
The Company computes basic and diluted earnings per share by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share are similarly calculated with the inclusion of dilutive common stock equivalents. For the year ended December 31, 2024, basic and dilutive net income (loss) per common share were the same since the inclusion of common shares issuable pursuant to the exercise of options, warrants, and vesting of restricted units in the calculation of diluted net loss per common shares would have been anti-dilutive.
The following table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net loss per common share for the year ended December 31, 2024 and for the period from March 15, 2023, to December 31, 2023.
| (in thousands) | Year Ended December 31,2024 | Period from March 15, 2023 to December 31, 2023 |
|---|---|---|
| Stock options | 1,627 | 985 |
| Restricted stock units | 558 | 821 |
| Warrants | 21,032 | 21,032 |
| Total | 23,217 | 22,838 |
Fair Value Measurements
FASB ASC 820, “Fair Value Measurements” (“ASC 820”), provides guidance on the development and disclosure of fair value measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles in the United States, and expands disclosures about fair value measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:
| ● | Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. |
| ● | Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. |
| ● | Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. |
Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management. The fair value of the warrants has been measured based on the listed market price of such warrants, a Level 1 measurement. For the year ended December 31, 2024, and for the period from March 15, 2023 to December 31, 2023, the Company recognized an unrealized loss in the Statements of Operations and Comprehensive Income of $3,365 thousand and $4,714 thousand, respectively, which are presented as changes in fair value of derivative liability.
The Company accounts for its public and private warrants as a derivative liability initially measured at its fair values and remeasured in the consolidated statements of operations at the end of each reporting period. When the warrants are exercised, the corresponding derivative liability is de-recognized at the underlying fair value of the Class A common stock that is issued to the warrant holder less any cash paid in accordance with the warrant agreement. Upon either cash or cashless exercise, the de-recognized derivative liability results in an increase in additional paid in capital equal to the difference between the fair value of the underlying Class A common stock and its par value. A cashless exercise results in the warrant holder surrendering Class A common stock equal to the stated warrant exercise price based on the contractual terms in the warrant agreement that governs the cashless conversion.
The following table shows the changes in fair value of the liabilities during the period ended December 31, 2024:
| Warrant liability - January 1, 2024 | $1,683 |
|---|---|
| Change in FV of derivative instruments | 3,365 |
| Warrant liability – December 31, 2024 | $5,048 |
| Warrant liability - March 15, 2023 | $2,649 |
|---|---|
| Change in FV of derivative instruments | 4,714 |
| FV of Warrants exchanged for Class A common stock (see Note 10 - Warrants) | (1,914) |
| FV of Warrants exercised for Class A common stock (see Note 10 - Warrants) | (766) |
| Warrant liability - December 31, 2023 | $1,683 |
The Company accounts for convertible debt under the fair value option election using Level 3 inputs. For the year ended December 31, 2024, and for the period from March 15, 2023 to December 31, 2023, the Company recognized an unrealized gain in the Consolidated Statements of Operations and Comprehensive Income (Loss) of $213 thousand and $0 thousand, respectively, which are presented as change in fair value of derivative liability. See additional details withinNote 12, Convertible debt.
The significant inputs in the valuations models for each of the three issuances were as follows:
Pre-Paid Purchase #1
| Schedule of valuation models | ||
|---|---|---|
| Inputs | June 30, 2024 | December 31, 2024 |
| Valuation method | Scenario based analysis | Scenario based analysis |
| Stock price | $2.67 | $1.82 |
| Equity dividend yield | 0.00% | 0.00% |
| Expected term (years) | 3.00 | 2.42 |
| Volatility | 106.2% | 100.8% |
| Discount rate | 13.9% | 11.8% |
| Risk free rate | 4.57% | 4.22% |
Pre-Paid Purchase #2
| Inputs | September 30, 2024 | December 31, 2024 |
|---|---|---|
| Valuation method | Scenario based analysis | Scenario based analysis |
| Stock price | $1.68 | $1.82 |
| Equity dividend yield | 0.00% | 0.00% |
| Expected term (years) | 2.68 | 2.42 |
| Volatility | 106.2% | 100.8% |
| Discount rate | 11.6% | 11.8% |
| Risk free rate | 3.58% | 4.22% |
Pre-Paid Purchase #3
| Inputs | December 9, 2024 | December 31, 2024 |
|---|---|---|
| Valuation method | Scenario based analysis | Scenario based analysis |
| Stock price | $2.25 | $1.82 |
| Equity dividend yield | 0.00% | 0.00% |
| Expected term (years) | 2.48 | 2.42 |
| Volatility | 100.8% | 100.8% |
| Discount rate | 11.3% | 11.8% |
| Risk free rate | 4.07% | 4.22% |
Fair Value of Financial Instruments
Financial instruments consist of cash and cash equivalents, accounts receivable, unbilled and other receivables and accounts payable. The Company determines the estimated fair value of such financial instruments presented in the financial statements is equal to its carrying value due to their short-term nature.
Carrying Value, Recoverability and Impairment of Long-Lived Assets
The Company follows FASB ASC 360 “Property, Plant, and Equipment” (“ASC 360”) for its long-lived assets. Pursuant to ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. Pursuant to ASC 360-10-35-20, if an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited.
Pursuant to ASC 360-10-35-21, the Company’s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company considers the following to be some examples of such events or changes in circumstances that may trigger an impairment review: (a) significant decrease in the market price of a long-lived asset (asset group); (b) a significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition; (c) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator; (d) an accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group); (e) a current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset (asset group); and (f) a current expectation that, more likely than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company tests its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.
Based on its assessments, the Company recordedno impairment charges on long-lived assets for the year ended December 31, 2024 (Successor), for the period from March 15, 2023, to December 31, 2023 (Successor), and for the period from January 1, 2023, to March 14, 2023 (Predecessor).
Recently Adopted Accounting Pronouncement
In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”. The disclosure requirements are required on an annual and interim basis and are applicable to entities with a single reportable segment. The amendments in the ASU require disclosures to include significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment’s profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 31, 2024, with early adoption allowed. We adopted this guidance as of January 1, 2024, on a retrospective basis and the adoption did not have a material impact on our consolidated financial statements. SeeNote 16, Segment Information, in the accompanying notes to the consolidated financial statements for further detail.
Recently Issued Accounting Standards Not Yet Adopted
In March 2024, the FASB issued ASU 2024-01, “Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards,” which clarifies how an entity determines whether a profits interest or similar award is within the scope of Topic 718 or is not a share-based payment arrangement and therefore within the scope of other guidance. ASU 2024-01 adds an example with multiple fact patterns and illustrates how an entity evaluates common terms and characteristics of profits interests and similar awards to reach a conclusion about whether an award meets the conditions in Topic 718. It also amends certain language in the “Scope” and “Scope Exceptions” sections of Topic 718 to improve its clarity and operability without changing the guidance. ASU 2024-01 is effective for the Company for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Entities may apply the guidance either retrospectively to all periods presented in the financial statements or prospectively to profits interest and similar awards granted or modified on or after the date of adoption. We are currently evaluating the impact of this standard on our consolidated financial statements.
In March 2024, the FASB issued ASU 2024-02 “Codification Improvements—Amendments to Remove References to the Concept Statements”, which amends the Codification to remove references to various FASB Concepts Statements and impacts a variety of Topics in the Codification. The amendments apply to all reporting entities within the scope of the affected accounting guidance, but in most instances the references removed are extraneous and are not required to understand or apply the guidance. Generally, the amendments in ASU 2024-02 are not intended to result in significant accounting changes for most entities. ASU 2024-02 is effective for the Company for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Entities may apply the guidance either retrospectively to the beginning of the earliest comparative period presented or prospectively to all new or modified transactions recognized on or after the date of adoption. We are currently evaluating the impact of this standard on our consolidated financial statements.
In November 2024, the FASB issued ASU No. 2024-03 “Disaggregation of Income Statement Expenses”. The amendment requires more detailed information about specified categories of expenses (purchases of inventory, employee compensation, depreciation, amortization, and depletion) included in certain expense captions presented on the face of the income statement. This ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this ASU or (2) retrospectively to all prior periods presented in the financial statements. We are currently evaluating the impact this ASU will have on our disclosures.
In November 2024, the FASB issued ASU No. 2024-04 “Debt—Debt with Conversion and Other Options (Subtopic 470-20)”. The amendment requires companies to apply a preexisting contract approach. Under this approach, a settlement qualifies for induced conversion accounting if the inducement offer preserves the form of consideration and results in an amount of consideration that is no less than that issuable pursuant to the preexisting conversion privileges. The ASU is effective for all entities in annual and interim reporting periods in fiscal years beginning after December 15, 2025. Early adoption permitted for entities that have adopted the amendments in Update 2020-06. The amendments may be applied either (1) prospectively to any settlements of convertible debt instruments that occur after the effective date of this ASU or (2) retrospectively to all prior periods that occurred after the adoption of the amendments in Update 2020-06. We are currently evaluating the impact this ASU will have on our disclosures.
NOTE 3 –Business Combination
On March 14, 2023, the Company completed the Agreement and Plan of Merger (the “Merger Agreement”), by and among KINS, Inpixon, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (“Merger Sub”), pursuant to which KINS combined with Legacy CXApp, Inpixon’s enterprise apps business (including its employee experience technologies, indoor mapping, events platform, augmented reality and related business solutions) (the “Enterprise Apps Business”). In exchange for the aggregate purchase price of approximately $69,928 thousand, the Company acquired all of the related assets and liabilities of Legacy CXApp. The consideration transferred in connection with the Business Combination consisted of 1,547,700 shares of the Company’s Class A Common Stock and 5,487,300 shares of the Company’s Class C Common Stock valued at a price of $9.94 per share. The preliminary estimated goodwill of approximately $44,200 thousand arising from the Business Combination consists of an acquired workforce, as well as synergies expected from combined operations of KINS and the CXApp.
The Company has authorized Class A and Class C common stock. Class A common stock and New CXApp Class C common stock are identical in all respects, except that New CXApp Class C common stock is not listed and will automatically convert into New CXApp Class A common stock on the earlier to occur of (i) the 180 th day following the closing of the Merger which has expired and (ii) the day that the last reported sale price of New CXApp Class A common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period following the closing of the Merger.
The Business Combination is being accounted for as a business combination in accordance with ASC 805. The Company has determined preliminary fair values of the assets acquired and liabilities assumed in the Business Combination.
The Company allocated the purchase price of the Business Combination to the assets acquired and the liabilities assumed as of the closing date. The following table summarizes the purchase price allocations relating to the Business Combination (in thousands):
| Description | Fair Value | Weighted AverageUseful Life(in years) |
|---|---|---|
| Purchase Price | $69,928 | |
| Assets acquired: | ||
| Cash and cash equivalents | $10,003 | |
| Accounts receivable | 2,226 | |
| Notes and other receivables | 209 | |
| Prepaid assets and other current assets | 408 | |
| Operating lease right of use asset | 557 | 3 years |
| Property and equipment, net | 133 | 3 years |
| Other assets | 42 | |
| Developed technology | 8,697 | 10 years |
| Patents | 2,703 | 10 years |
| Customer relationships | 5,604 | 5 years |
| Trade names and trademarks | 3,294 | 7 years |
| Total assets acquired | $33,876 | |
| Liabilities assumed: | ||
| Accounts payable | $443 | |
| Accrued liabilities | 969 | |
| Deferred revenues | 2,534 | |
| Operating lease obligation, current | 194 | |
| Operating lease obligation, noncurrent | 384 | |
| Deferred tax liability | 4,217 | |
| Total liabilities assumed | 8,741 | |
| Goodwill | $44,793 | |
The value of the intangible assets were calculated by a third party valuation firm based on projections and financial data provided by management of the Company. Goodwill represents the excess fair value after allocation to the intangible assets. The calculated goodwill is not deductible for tax purposes.
Total acquisition-related costs for the Business Combination were approximately $3,543 thousand. Of the total acquisition-related costs, approximately $3,000 thousand were incurred by KINS prior to the close of the Business Combination. These costs are included in the opening retained earnings of the Company on March 15, 2023. The remaining $543 thousands of acquisition-related costs were recorded as expense in the successor period and are included in acquisition related costs on the statements of operations for the period from March 15, 2023 to December 31, 2023 (Successor).
Measurement Period
The purchase price allocations for the acquisitions described above are based on initial estimates and provisional amounts. In accordance with ASC 805-1025-13, if the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, the acquirer shall report in its financial statements’ provisional amounts for the items for which the accounting is incomplete. During the measurement period, acquirer shall adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. The Company continued to refine its inputs and estimates inherent in (i) the valuation of intangible assets, (ii) deferred income taxes, (iii) realization of tangible assets and (iv) the accuracy and completeness of liabilities through March 14, 2024, when the purchase price allocation was finalized.
CXApp Pro Forma Financial Information
The following pro forma financial information presents the consolidated balance sheet and results of operations of the Company for the year ended December 31, 2023, as if the acquisition had occurred as of the beginning of the first period presented (January 1, 2023). The pro forma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during those periods.
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEETS
| Assets | |
|---|---|
| Current assets | $9,029 |
| Noncurrent assets | 27,552 |
| Total assets | $36,581 |
| Liabilities | |
| Current liabilities | $10,316 |
| Noncurrent liabilities | 867 |
| Total liabilities | $11,183 |
| Stockholders’ equity | $25,398 |
| Total stockholders’ equity | $25,398 |
| Total liabilities and equity | $36,581 |
**UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)
| Revenues | $7,366 |
|---|---|
| Net loss | $(57,904) |
NOTE 4 –Disaggregation of Revenue
The Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from software as a service, design and implementation services for its enterprise apps solutions systems, professional services for work performed in conjunction with its systems, and sale of hardware.
Revenues consisted of the following (in thousands):
| Successor · Predecessor | |||
|---|---|---|---|
| Year ended December 31, 2024 | Period from March 15, 2023, to December 31, 2023 | Period from January 1, 2023, to March 14, 2023 | |
| Subscription revenue | |||
| Software | $6,202 | $4,560 | $1,204 |
| Total subscription revenue | $6,202 | $4,560 | $1,204 |
| Non-subscription revenue | |||
| Professional services | $798 | $1,186 | $416 |
| Hardware | 142 | - | - |
| Total non-subscription revenue | $940 | $1,186 | $416 |
| Total revenue | $7,142 | $5,746 | $1,620 |
| Successor · Predecessor | |||
|---|---|---|---|
| Year ended December 31, 2024 | Period from March 15, 2023, to December 31, 2023 | Period from January 1, 2023, to March 14,2023 | |
| Revenue recognized over time(1)(2) | $7,000 | $5,746 | $1,620 |
| Revenue recognized at a point in time(3) | 142 | - | - |
| Total | $7,142 | $5,746 | $1,620 |
| (1) | Professional services are also contracted on the fixed fee and time and materials basis. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has generally elected the practical expedient to recognize revenue for the right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date. |
| (2) | Software As a Service Subscription Revenue’s performance obligation is satisfied evenly over the service period using a time-based measure because the Company is providing continuous access to its service and service is recognized over time. |
| (3) | Hardware revenue is recognized at a point in time when the control over the goods transfers to the customer - upon delivery to the customers. |
NOTE 5 –Property and Equipment, net
Property and equipment consisted of the following (in thousands):
| December 31,2024 | December 31,2023 | |
|---|---|---|
| Computer and office equipment | $177 | $179 |
| Furniture and fixtures | 11 | 12 |
| Leasehold improvements | 4 | 6 |
| Software | - | 1 |
| Total | 192 | 198 |
| Less: accumulated depreciation and amortization | (128) | (83) |
| Total Property and Equipment, Net | $64 | $115 |
Depreciation and amortization expense was approximately $79 thousand, $75 thousand, and $19 thousand for the year ended December 31, 2024 (Successor), for the period from March 15, 2023, to December 31, 2023 (Successor), and for the period from January 1, 2023 to March 14, 2023 (Predecessor), respectively.
NOTE 6 –Goodwill and Intangible Assets, net
The Company reviews goodwill for impairment on a reporting unit basis annually on November 30 (beginning with fiscal year 2024) and whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The carrying amount of goodwill as of December 31, 2024, was $8,737 thousand, which is attributable to the business combination noted in Note 3.
We first assess qualitative factors, such as macroeconomic conditions, changes in the business environment, and reporting unit-specific events, to determine whether it is more likely than not that the fair value of a reporting unit is less than it carrying amount. If we bypass the qualitative assessment or conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we perform a quantitative impairment test by comparing the fair value of the reporting unit with its carrying amount. For the quantitative test, we calculate the estimated fair value using a weighting of the income and market approaches.
2024 Impai rment Assessment
For the year ended December 31, 2024, we completed our annual goodwill impairment evaluation as of November 30, 2024. No impairment loss was recognized for the year ended December 31, 2024. The value of goodwill as of December 31, 2024, remains consistent with the post-impairment balance reported as of December 31, 2023.
2023 Impairment Assessment
For the period from March 15, 2023, to December 31, 2023 (Successor), the Company recognized a goodwill impairment loss of $36,056 thousand. This impairment resulted from declines in market capitalization, revised cash flow projections, and adverse changes in market conditions impacting the recoverability of goodwill. For the period January 1, 2023, to March 14, 2023 (Predecessor), the Company recognized a goodwill impairment loss of $0 thousand.
Goodwill consisted of the following (in thousands):
| Acquisition | Amount |
|---|---|
| Balance as of March 15, 2023 · $ · - | |
| Acquisition of Legacy CXApp | 44,122 |
| Measurement Period Adjustments | 671 |
| Impairment | (36,056) |
| Balance as of December 31, 2023 | $8,737 |
Intangible assets consisted of the following (in thousands):
| December 31, 2024 · December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|
| Weighted Average Remaining Useful Life (Years) | Gross Amount | Accumulated Amortization | Net Carrying Amount | Gross Amount | Accumulated Amortization | Net Carrying Amount | |
| Trade Name/Trademarks | 5.17 | $3,294 | $(843) | $2,451 | $3,294 | $(373) | $2,921 |
| Customer Relationships | 3.17 | 5,604 | (2,008) | 3,596 | 5,604 | (887) | 4,717 |
| Developed Technology | 8.17 | 8,697 | (1,558) | 7,139 | 8,697 | (688) | 8,009 |
| Patents and Intellectual Property | 8.17 | 2,703 | (485) | 2,218 | 2,703 | (214) | 2,489 |
| Totals | $20,298 | $(4,894) | $15,404 | $20,298 | $(2,162) | $18,136 | |
Future amortization expense on intangible assets as of December 31, 2024, is anticipated to be as follows (in thousands):
| For the Years Ending December 31, | Amount |
|---|---|
| 2025 | $2,731 |
| 2026 | 2,731 |
| 2027 | 2,731 |
| 2028 | 1,844 |
| 2029 | 1,611 |
| 2030 and thereafter | 3,756 |
| Total | $15,404 |
NOTE 7 –Deferred Revenue
Deferred revenue consisted of the following (in thousands):
| Successor | |||||
|---|---|---|---|---|---|
| License Agreement · ProfessionalServiceAgreements · Hardware · Total | |||||
| Deferred Revenue - January 1, 2024 | $2,404 | $474 | $ | - | $2,878 |
| Revenue recognized | (6,202) | (798) | (142) | (7,142) | |
| Revenue deferred | 6,402 | 385 | 160 | 6,947 | |
| Deferred Revenue - December 31, 2024 | $2,604 | $61 | $18 | $2,683 | |
| License Agreement · ProfessionalServiceAgreements · Hardware · Total | |||||
|---|---|---|---|---|---|
| Deferred Revenue - March 15, 2023 | $2,148 | $386 | $ | - | $2,534 |
| Revenue recognized | (4,560) | (1,186) | - | (5,746) | |
| Revenue deferred | 4,816 | 1,274 | - | 6,090 | |
| Deferred Revenue - December 31, 2023 | $2,404 | $474 | $ | - | $2,878 |
| Predecessor | |||||
|---|---|---|---|---|---|
| License Agreement · Professional Service Agreements · Hardware · Total | |||||
| Deferred Revenue - January 1, 2023 | $1,931 | $231 | $ | - | $2,162 |
| Revenue recognized | (1,204) | (416) | - | (1,620) | |
| Revenue deferred | 1,421 | 571 | - | 1,992 | |
| Deferred Revenue - March 14, 2023 | $2,148 | $386 | $ | - | $2,534 |
Deferred revenues were approximately $2,683 thousand and $2,878 thousand as of December 31, 2024, and December 31, 2023, respectively.
The fair value of the deferred revenue approximates the services to be rendered.
NOTE 8 –Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
| December 31,2024 | December 31,2023 | |
|---|---|---|
| Accrued expenses and reimbursements | $1,690 | $858 |
| Accrued compensation and benefits | 382 | 387 |
| Accrued bonus and commissions | 134 | 108 |
| Accrued sales and other indirect taxes payable | 95 | 12 |
| Accrued insurance premium and interest | 23 | - |
| Accrued transaction costs | 13 | 13 |
| Income Tax Payables | 46 | 74 |
| Accrued liabilities | $2,383 | $1,452 |
Financed Director & Officers Insurance
The Company entered into a Directors & Officers (“D&O”) insurance agreement with Oakwood D&O Insurance, effective on March 14, 2024. The agreement states that the Company will pay a total of $310 thousand in premiums at an annual percentage rate of 9.5%. The first of ten monthly separate installment payments begin on April 14, 2024. The Company paid a down payment on the policy of $85 thousand. As of December 31, 2024, the Company currently owes $23 thousand on the D&O insurance policy.
NOTE 9 –Promissory Note
Promissory note consisted of the following (in thousands):
| Schedule of promissory note | |||||
|---|---|---|---|---|---|
| December 31, 2024 · December 31, 2023 | |||||
| Principal amount | $3,885 | $3,885 | |||
| Less: | Unamortized original issue discount | - | 834 | ||
| Unamortized debt issuance cost | - | 14 | |||
| 3,885 | 3,037 | ||||
| Add: Interest | 372 | 16 | |||
| Accrued monitoring fee | 273 | - | |||
| 4,530 | 3,053 | ||||
| Less: | Extinguishment | 3,927 | - | ||
| $603 | $3,053 | ||||
December 2023 Promissory Note
On December 15, 2023, the Company entered into a note purchase agreement with Streeterville Capital, LLC (the “Lender”), pursuant to which we agreed to issue and sell to the Lender an unsecured promissory note (the “Note”) in an aggregate initial principal amount of $3,885 thousand, which is payable on or before the date that is 12 months from the issuance date. The initial principal amount includes an original issue discount of $870 thousand and $15 thousand that we agreed to pay to the Lender to cover the Lender’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. The net proceeds of the Note are $3,000 thousand.
Interest on the Note accrues at a rate of 10% per annum and is payable on the maturity date.
A monitoring fee of 10% of the outstanding balance will be charged starting six (6) months from the issuance of the Note to cover Lender’s accounting, legal and other costs incurred in monitoring. The foregoing fee shall automatically be added to the outstanding balance on the applicable date without any further action by either party.
The Lender shall have the right to redeem up to an aggregate of 1/6th of the initial principal balance of the Note plus any interest accrued thereunder each month by providing written notice delivered to us; provided, however, that if the Lender does not exercise any monthly redemption amount in its corresponding month then such monthly redemption amount shall be available for the Lender to redeem in any further month in addition to such future month’s monthly redemption amount.
Upon receipt of any monthly redemption notice, we shall pay the applicable monthly redemption amount in cash to the Lender within five (5) business days of the Company’s receipt of such monthly redemption notice.
The Note includes customary event of default provisions, subject to certain cure periods, and provides for a default interest rate of 22%. Upon the occurrence of an event of default, interest would accrue on the outstanding balance beginning on the date the applicable event of default occurred at an interest rate equal to the lesser of twenty-two percent (22%) or the maximum rate permitted under applicable law.
Note Exchanges
During the period from July 15, 2024, to December 26, 2024, the Company exchanged $3,428 thousand of the outstanding balance of the Note for approximately 2,012,107 shares of the Company’s Class A Common Stock at exchange prices between $1.47 and $2.23 per share.
The Company analyzed the exchange of principal under the note as an extinguishment and compared the net carrying value of the debt being extinguished to the reacquisition price (shares of common stock being issued) and recorded an approximately $1,052 thousand loss on the exchange of debt for equity as a separate item in the other income (expense) section of the consolidated statements of operations for the year ended December 31, 2024.
As of January 17, 2025, the Company paid down the entire December 2023 Note.
Interest expense for the December 2023 Note recognized on the consolidated statement of operations and comprehensive loss were approximately $1,069 thousand and $53 thousand for the year ended December 31, 2024, and period from March 15, 2023 to December 31, 2023 (Successor), respectively.
NOTE 10 –Warrants
Public Warrants
As of December 31, 2024, and December 31, 2023, there were 10,751,862 Public Warrants outstanding. Each whole warrant entitles the holder thereof to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustments described in the Company’s registration statement on Form S-1 (Registration No. 333-249177) filed in connection with its initial public offering.
The Public Warrants is exercisable and will expire on March 15, 2028, or earlier upon redemption or liquidation. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
On July 13, 2023, warrant holders exercised 435,000 public warrants at an exercise price of $11.50, for a total of $5,002 thousands of cash proceeds to the Company.
On July 14, 2023, the Company entered into a Warrant Exchange Agreement (the “Agreement”) with an unaffiliated third party investor (the “Warrant Holder”) with respect to warrants to purchase an aggregate of 2,000 thousand shares of its common stock, par value $0.0001 per share (the “Common Stock”) initially issued by the Company in its initial public offering on December 15, 2020 (the “Public Warrants”). Pursuant to the Agreement, the Company issued an aggregate of 600 thousand shares of Common Stock to the Warrant Holder in exchange for the surrender and cancellation of the Public Warrants held by such holder. This resulted to an additional paid in capital of $4,914 thousand in a non-cash transaction and resulted in a $3,900 thousand loss on the warrant conversion, which is included in change in fair value of derivative liability in the statement of operations.
In June 2023, about 613,138 public warrants to purchase Class A common stock were exercised on a cashless basis for approximately 50 thousand shares of common stock and are no longer outstanding.
Private Warrants
As of December 31, 2024, and December 31, 2023, there were 10,280,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until April 14, 2023, subject to certain limited exceptions.
Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
For the year ended December 31, 2024, there were no exercises or exchanges made in relation with the Company’s Warrants. The number of outstanding Public and Private Warrants as of December 31, 2024, is the same as that of December 31, 2023.
Public and private warrant exercise activity and underlying Common Stock issued or surrendered for the period from March 15, 2023 to December 31, 2023 (Successor) and for the period from January 1, 2023, to March 14, 2023 (Predecessor), is:
| Public Warrants | PrivateWarrants | Total | |
|---|---|---|---|
| January 1, 2023 | 13,800,000 | 10,280,000 | 24,080,000 |
| Warrants exchanged | (2,000,000) | - | (2,000,000) |
| Warrants exercised – cash | (435,000) | - | (435,000) |
| Warrants exercised – cashless | (613,138) | - | (613,138) |
| December 31, 2023 | 10,751,862 | 10,280,000 | 21,031,862 |
NOTE 11 –Stock Option Plan and Stock-Based Compensation
2023 Equity Incentive Plan
At the special meeting held on March 10, 2023, the KINS stockholders considered and approved, among other things, the Incentive Plan. The Incentive Plan was previously approved, subject to stockholder approval, by KINS’ board of directors. The Incentive Plan became effective immediately upon the closing of the Business Combination. Pursuant to the terms of the Incentive Plan, there are 2,110,500 shares of CXApp Class A Common Stock available for issuance under the Incentive Plan, which is equal to 15% of the aggregate number of shares of CXApp common stock issued and outstanding immediately after the closing of the Business Combination (giving effect to the redemptions).
Employee Stock Options
To calculate the stock-based compensation resulting from the issuance of options, the Company uses the Black-Scholes option pricing model, which is affected by the Company’s fair value of its stock price as well as assumptions regarding a number of subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors.
On February 6, 2024, a total of 665,000 stock options to purchase the Company’s common stock were granted to employees and consultants of the Company. These options vest over a 4-year period. The options have a life of 10 years and an exercise price of $1.20 per option. The stock options were valued using the Black-Scholes option valuation model and the weighted average fair value of the awards granted during the period was determined to be $0.78 per option on the grant date. The fair value of the common stock as of the grant date utilized in the Black-Scholes option valuation model was $1.21 per share.
In June 2024, the Company received a notice for a net exercise of 70,350 options to purchase shares of common stock resulting in the issuance of 12,570 shares of the Company’s Class A Common Stock with par value $0.0001 per share. In accordance with the terms of the Incentive Plan, 51,012 shares were withheld by the Company to cover the exercise price, and 6,768 shares were withheld in satisfaction of the taxes required to be paid in connection with the exercise.
On August 26, 2024, the Board approved the award of 230,000 options to purchase common stock pursuant to the 2023 Equity Incentive Plan to Joy Mbanugo, the Chief Financial Officer of the Company. The option has an exercise price of $2.40 per share. The options expire on August 26, 2034. The stock options were valued using the Black-Scholes option valuation model and the fair value of the awards granted was determined to be $1.49 per option on the grant date. The fair value of the common stock as of the grant date utilized in the Black-Scholes option valuation model was $2.40 per share.
See below for a summary of the stock options granted under the Incentive Plan:
| Schedule of stock options activity | |||||
|---|---|---|---|---|---|
| Number ofOptions | Weighted-averageexerciseprice | Weightedaverageremainingcontractualterm (years) | Weighted-Average Fair Value atGrant Date | Aggregate Intrinsic Value (In thousands) | |
| Options outstanding at January 1, 2024 | 984,900 | $1.53 | 9.25 | $0.90 | |
| Granted | 895,000 | $1.51 | 9.25 | $0.96 | |
| Exercised | (70,350) | $1.53 | $0.90 | $108 | |
| Forfeited | (10,000) | $1.20 | |||
| Options outstanding at December 31, 2024 | 1,799,550 | $1.52 | 8.74 | $0.93 | |
| Options exercisable at December 31, 2024 | 422,100 | $1.53 | |||
| Number ofOptions · Weighted-averageexerciseprice · Weightedaverageremainingcontractualterm (years) · Weighted-Average Fair Value atGrant Date | |||||
|---|---|---|---|---|---|
| Options outstanding at January 1, 2023 · - · $ · - · - · $ · - | |||||
| Granted | 1,377,172 | $1.53 | |||
| Forfeited | (392,272) | $1.53 | |||
| Options outstanding at December 31, 2023 | 984,900 | $1.53 | 9.25 | $0.90 | |
| Options exercisable at December 31, 2023 | - | $ | - | - | - |
Non-cash stock-based compensation expenses related to stock option were recorded in the financial statements as summarized below:
| Successor · Predecessor | |||||
|---|---|---|---|---|---|
| Year ended December 31, 2024 · Period from March 15, 2023, to December 31, 2023 · Period from January 1, 2023, to March 14, 2023 | |||||
| Research and development | $18 | $ | - | $ | - |
| Sales and marketing | 81 | - | - | ||
| General and administrative | 454 | 113 | 158 | ||
| Total non-cash stock compensation | $553 | $113 | $158 | ||
As of December 31, 2024, the remaining unrecognized stock compensation expense totaled approximately $574 thousand. This amount will be recognized as an expense over the weighted average remaining term of 2.55 years.
The fair value of each employee option grant is estimated on the date of the grant using the Black-Scholes option-pricing model. Key weighted-average assumptions used to apply this pricing model during the year ended December 31, 2024 (Successor) were as follows:
| 2024 | 2023 | |
|---|---|---|
| Risk-free interest rate | 3.66% - 4.03% | 3.67% |
| Expected life of option grants | 6 – 6.25 years | 5.75 years |
| Expected volatility of underlying stock | 65.17% - 65.97% | 61.65% |
| Dividends assumption | $- | $- |
Restricted Stock Units
The grant date fair value for Restricted Stock Units (RSU) are valued using the closing price of the Company’s common stock on the date of grant.
On January 2024, a total of 47,000 restricted stock units of the Company’s common stock were granted to employees of the Company under the Incentive Plan at various dates.
On August 29, 2024, a total of 473,935 restricted stock units of the Company’s common stock were granted to directors of the Company under the 2023 Equity Incentive Plan.
The fair value of the common stock as of the various grant dates was determined to be $1.25 to $2.11 per restricted stock unit, for a weighted average fair value of $2.04 per restricted stock unit. There was no other activity related to restricted stock units for the year ended December 31, 2024.
The following summarizes our RSUs transaction activity for the year ended December 31, 2024:
| Shares | Weighted Average Grant Date Fair Value | |
|---|---|---|
| Outstanding at January 1, 2024 | 486,165 | $7.80 |
| Granted | 520,935 | $2.04 |
| Vested | (318,165) | $7.33 |
| Forfeited | - | |
| Outstanding at December 31, 2024 | 688,935 |
| Shares | Weighted Average Grant Date Fair Value | |
|---|---|---|
| Outstanding at March 15, 2023 | - | $ |
| Granted | 526,165 | $7.80 |
| Forfeited | (40,000) | $7.13 |
| Outstanding at December 31, 2023 | 486,165 |
The total fair value of RSUs vested during the year ended December 31, 2024, was $2,331 thousand. There wasno RSUs vested during the year ended December 31, 2023.
Non-cash stock-based compensation expenses related to restricted stock units recorded in the financial statements is summarized below:
| Successor | |||
|---|---|---|---|
| Year ended December 31, 2024 · Period from March 15, 2023, to December 31, 2023 | |||
| Research and development | $605 | $ | - |
| Sales and marketing | 310 | - | |
| General and administrative | 1,363 | 686 | |
| Total non-cash stock compensation | $2,278 | $686 | |
As of December 31, 2024, and December 31, 2023, the Company has approximately $1,016 thousand and $1,796 thousands of unrecognized restricted stock unit compensation to be expensed over a weighted average period of 0.91 year and 1.42 years, respectively.
NOTE 12 –Convertible Debt
On May 22, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”), pursuant to which the Lender desires to purchase up to $10,000,000 shares of the Company’s Common Stock and the Company issued an unsecured convertible Pre-Paid Purchase #1 to Streeterville Capital, LLC (“Lender”). The SPA required 40,000 common shares of the Company’s Class A Common Stock to be issued as of closing date (May 22, 2024). The Company recorded a liability of $130,400 on May 22, 2024, for the shares to be issued within contract to issue common stock. The Company issued the Class A Common Stock on October 10, 2024, and recorded a gain of $68 thousand on settlement of the contract to issue common stock.
The convertible Pre-Paid Purchase #1 has the original principal amount of $2,625 thousand and Lender gave consideration of $2,480 thousand, reflecting original issue discount of $125 thousand and Lender’s transaction cost of $20 thousand. On June 3, 2024, the Company received the net proceeds from the Lender.
The convertible Pre-Paid Purchase #1 accrues interest on the outstanding balance at 5% per annum. The Lender may redeem all or any part of the outstanding balance of the convertible Pre-Paid Purchase #1, at any time following earlier of six months from the purchase price date and the effectiveness of the Initial Registration Statement by providing a written notice, in cash or converting into shares of the Company’s common stock at a price equal to the lower of (a) Fixed Price of $3.996 and (b) Market Price which is 91% multiplied by the lowest daily volume weighted average price (“VWAP”) during the ten (10) consecutive trading days immediately prior to the written notice date, but in any event not lower than the Floor Price of $0.666, subject to certain adjustments and ownership limitations specified in the convertible Pre-Paid Purchase. The Pre-Paid Purchase #1 was recorded at its initial fair value of $2,562 thousand and the Company recognized an unrealized gain on change in fair value of convertible debt of $63 thousand. As of December 31, 2024, Pre-Paid Purchase #1 is recorded at fair value of $543 thousand and is within convertible debt on the accompanying consolidated balance sheets. For the twelve months ended December 31, 2024, the Company recognized an unrealized loss on change in fair value of Pre-Paid Purchase #1 of $18 thousand.
On September 30, 2024, the Company issued an unsecured convertible Pre-Paid Purchase #2 to the Lender, pursuant to the SPA. The convertible Pre-Paid Purchase #2 has the original principal amount of $1,050 thousand and Lender gave consideration of $1,000 thousand, reflecting original issue discount of $50 thousand. On September 30, 2024, the Company received the net proceeds from the Lender.
The convertible Pre-Paid Purchase #2 accrues interest on the outstanding balance at 5% per annum. The Lender may redeem all or any part of the outstanding balance of the convertible Pre-Paid Purchase #2, at any time following earlier of six months from the purchase price date and the effectiveness of the Initial Registration Statement by providing a written notice, in cash or converting into shares of the Company’s common stock at a price equal to the lower of (a) Fixed Price of $1.992 and (b) Market Price which is 91% multiplied by the lowest daily volume weighted average price (“VWAP”) during the ten (10) consecutive trading days immediately prior to the written notice date, but in any event not lower than the Floor Price of $0.332, subject to certain adjustments and ownership limitations specified in the convertible Pre-Paid Purchase. The Pre-Paid Purchase #2 was recorded at its initial fair value of $1,045 thousand and the Company recognized an unrealized gain on change in fair value of convertible debt of $5 thousand. As of December 31, 2024, Pre-Paid Purchase #2 is recorded at fair value of $1,028 and is within convertible debt on the accompanying consolidated balance sheets. For the twelve months ended December 31, 2024, the Company recognized an unrealized gain on change in fair value of Pre-Paid Purchase #2 of $23 thousand.
On December 9, 2024, the Company issued an unsecured convertible Pre-Paid Purchase #3 to the Lender, pursuant to the SPA. The convertible Pre-Paid Purchase #3 has the original principal amount of $3,150 thousand and Lender gave consideration of $3,000 thousand, reflecting original issue discount of $150 thousand. On December 9, 2024, the Company received the net proceeds from the Lender.
The convertible Pre-Paid Purchase #3 accrues interest on the outstanding balance at 5% per annum. The Lender may redeem all or any part of the outstanding balance of the convertible Pre-Paid Purchase #3, at any time following earlier of six months from the purchase price date and the effectiveness of the Initial Registration Statement by providing a written notice, in cash or converting into shares of the Company’s common stock at a price equal to the lower of (a) Fixed Price of $1.987 and (b) Market Price which is 91% multiplied by the lowest daily volume weighted average price (“VWAP”) during the ten (10) consecutive trading days immediately prior to the written notice date, but in any event not lower than the Floor Price of $0.331, subject to certain adjustments and ownership limitations specified in the convertible Pre-Paid Purchase. The Pre-Paid Purchase #3 was recorded at its initial fair value of $2,986 thousand. The Company recognized an unrealized gain on change in fair value of Pre-Paid #3 of $164 thousand. As of December 31, 2024, Pre-Paid Purchase #3 is recorded at fair value of $2,942 and is within convertible debt on the accompanying consolidated balance sheets. For the twelve months ended December 31, 2024, the Company recognized an unrealized gain on change in fair value of Pre-Paid Purchase #3 of $208 thousand.
The following table presents changes in convertible debt measured at fair value for the twelve months ended December 31, 2024. There was no convertible debt for the period from March 15, 2023, to December 31, 2023 (Successor) and for the period from January 1, 2023, to March 14, 2023 (Predecessor).
| Schedule of changes convertible debt measured at fair value | |
|---|---|
| Convertible debt | |
| Balance as of December 31, 2023 · $ · - | |
| Additions | 6,825 |
| Settlement(1) | (2,100) |
| Fair value measurement adjustments | (213) |
| Balance as of December 31, 2024 | $4,512 |
| (1) | During the year ended December 31, 2024, the Company has issued 1,683,104 shares of the Company’s Class A Common Stock pursuant to multiple purchase notices related to Pre-Paid Purchase #1. The shares issued have a total exchange amount of $2,100 thousand with exchange prices ranging from $1.18 to $1.41. |
NOTE 13 –Common Stock
In March 2023, the Company issued 100,000 shares of Class A Common Stock as a compensation to BTIG, LLC (BTIG) for the strategic and capital markets advisory services to be provided to the Company effective on the business day following the Business Combination.
Following the Business Combination, the Company’s Class C Common Stock is subject to transfer restrictions and will automatically convert into the Company’s Class A Common Stock on the earlier to occur of (i) the 180th day following the closing of the Merger and (ii) the day that the last reported sale price of the New CXApp Class A Common Stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period following the closing of the Merger.
On September 10, 2023, the Company’s 5,487,300 shares of Class C Common Stock were automatically converted into an aggregate of 5,487,300 shares of the Company’s Class A Common Stock, par value $0.0001 per share.
In June 2024, the Company received a notice for a net exercise of 70,350 options to purchase shares of common stock resulting in the issuance of 12,570 shares of the Company’s Class A Common Stock with par value $0.0001 per share. In accordance with the terms of the Incentive Plan, 51,012 shares were withheld by the Company to cover the exercise price, and 6,768 shares were withheld in satisfaction of the taxes required to be paid in connection with the exercise.
On October 10, 2024, the Company issued 40,000 shares of the Company’s Class A Common Stock as part of the Securities Purchase Agreement. The issued shares serve as the commitment shares of the agreement.
During the year ended December 31, 2024, the Company issued 246,220 shares of Class A Common Stock, net of 69,445 shares of Class A Common Stock to cover the withholding tax, for the 315,665 vested Restricted Stock Units.
During the year ended December 31, 2024, the Company issued total of 3,695,211 shares of Class A Common Stock for paying off the promissory note and the convertible debt. SeeNote 9, Promissory Note and Note 12, Convertible Debt, in the accompanying notes to the consolidated financial statements for further detail.
NOTE 14 –Income Tax
The Company’s net deferred tax assets/(liabilities) consisted of the effects of temporary differences attributable to the following:
| (In thousands) | December 31,2024 | December 31,2023 |
|---|---|---|
| Organizational costs/startup expenses | $1,432 | $1,031 |
| Deferred revenue | 23 | 41 |
| Section 174 - software development cost | 2,187 | 1,097 |
| Stock based compensation | 453 | 164 |
| Research credits | - | - |
| Other accruals | 16 | 50 |
| Fixed assets | - | - |
| Other | 2 | - |
| Net operating loss carryforward | 4,894 | 2,202 |
| Total deferred tax asset | 9,008 | 4,585 |
| Less: Valuation allowance | (5,498) | (871) |
| Deferred tax asset, net of valuation allowance | $3,510 | $3,714 |
| December 31,2024 · December 31,2023 | |||
|---|---|---|---|
| Intangibles | $(3,508) | $(4,338) | |
| Property, plant & equipment | (2) | (13) | |
| Other | - | ||
| Capitalized research | - | ||
| Total deferred tax liabilities | (3,510) | (4,351) | |
| Net Deferred Tax Asset (Liability) | $ | - | $(637) |
The income tax provision consists of the following for the years ended December 31, 2024, and 2023:
| Year ended December 31, 2024 · Period fromMarch 15, 2023 to December 31,2023 · Period fromJanuary 1, 2023 toMarch 14,2023 | ||||
|---|---|---|---|---|
| Foreign | ||||
| Current · $ · - · $ · - · $ · - | ||||
| Deferred | - | - | 4,054 | |
| Federal | ||||
| Current | - | (7) | - | |
| Deferred | (5,824) | (2,154) | (637) | |
| State and Local | ||||
| Current | 2 | 19 | - | |
| Deferred | (164) | (506) | (273) | |
| (5,986) | (2,648) | 3,144 | ||
| Change in valuation allowance | 5,350 | (924) | (3,144) | |
| Income tax expense/(benefit) | $(637) | $(3,572) | $ | - |
As of December 31, 2024, the Company has U.S. federal and state net operating loss carryover of approximately $7,494 thousand and $4,424 thousand respectively and Canada net operating loss carryover of approximately $11,353 thousand. The federal NOLs generated through 2017 which if unutilized will expire by the year 2037 and the federal NOLs generated after 2017 will be carried forward indefinitely whereas the state NOLs if unutilized will expire based on the state statutes.
The Canada NOLs which if able to be utilized will be carried forward through 2042. The Income Tax Act (Canada), or the “Canadian Tax Act”, and equivalent provincial income tax legislation may restrict the Company’s ability to carry forward non-capital losses from preceding tax years upon an acquisition of control.
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. In assessing the realization of deferred tax assets, management considers, whether it is “more likely than not”, that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Deferred income tax is presented under noncurrent liabilities and in other assets in the consolidated balance sheet as of December 31, 2024, and 2023, respectively.
In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the projected future taxable income and availability of taxable temporary differences in making this assessment. After consideration of all the information available, management believes that positive evidence does not outweighs the negative evidence and thus it is more likely than not that the benefit from deferred tax asset may not be realized in foreseeable future. In view of this, valuation allowance has been created as at December 31, 2024.
The Company’s policy for recording interest and penalties associated with unrecognized tax benefits is to record such interest and penalties as interest expense and as a component of income tax expense. There were no amounts accrued for interest or penalties for the years ended December 31, 2024, and 2023. Management does not expect any material changes in its unrecognized tax benefits in the next year.
A reconciliation of the federal income tax rate to the Company’s effective tax rate for the years ended December 31, 2024, and 2023 are as follows:
| Successor · Predecessor | ||||||
|---|---|---|---|---|---|---|
| Year ended December 31, 2024 · Period fromMarch 15, 2023 toDecember 31,2023 · Period fromJanuary 1, 2023 toMarch 14,2023 | ||||||
| Statutory federal income tax rate | 21.00% | 21.00% | 21.00% | |||
| Incentive stock options | - | % | - | % | (0.30)% | |
| Change in fair value of derivative warrant liabilities | (3.52)% | (2.18)% | - | % | ||
| Goodwill impairment loss | - | % | (14.34)% | - | % | |
| US-Foreign income tax rate difference | % | - | % | 1.30% | ||
| Permanent difference | (2.04)% | 0.22% | 0.07% | |||
| Cancellation of debt income | % | - | % | (101.38)% | ||
| Rate differential on foreign earnings | 0.44% | 0.24% | - | % | ||
| State taxes, net of federal tax benefit | (0.24)% | 0.93% | 3.49% | |||
| Current federal tax true-up | (1.27)% | 0.01% | - | % | ||
| Provision to return adjustments | % | - | % | - | % | |
| Deferred only adjustment | % | - | % | 4.80% | ||
| Other | % | - | % | (0.35)% | ||
| Valuation allowance | (11.20)% | 0.88% | 71.31% | |||
| Income tax provision | 3.17% | 6.76% | - | % | ||
The Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions as well as in foreign jurisdictions and is subject to examination by the various taxing authorities.
The Company recorded an income tax benefit/expense of approximately $637 thousand for the year ended December 31, 2024 (Successor).
The effective tax rate for the year ended December 31, 2024 (Successor) was 3.17%. The income tax benefit for the year ended December 31, 2024 (Successor) is a result of the reversal of deferred tax liability attributable to acquired intangible assets from the Business Combination. The company believes that positive evidence does not outweighs the negative evidence and thus it is more likely than not that the benefit from deferred tax asset may not be realized in foreseeable future. In view of this, valuation allowance has been created as of December 31, 2024.
Uncertain Tax Positions
The Company records tax positions as liabilities and adjusts these liabilities when its judgment changes because of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the Company’s current estimate of the recognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. As of December 31, 2024, and the period March 15, 2023, to December 31, 2023 (Successor) the Company has not recorded any liabilities for uncertain tax positions in its consolidated financial statements.
The Company records interest and penalties related to unrecognized tax benefits in the provision for income taxes. As of December 31, 2024 and the period March 15, 2023 to December 31, 2023 (Successor), no accrued interest or penalties are recorded on the balance sheets, and the Company has not recorded any related expenses. The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examinations by federal, foreign, and state and local jurisdictions, where applicable. There are currently no pending tax examinations. The Company’s tax years currently open under statute range from 2021 to the present in the U.S. and from 2020 to the present in its foreign operations. To the extent the Company has tax attribute carryforwards, the tax years in which those attributes were generated may remain subject to adjustment upon examination by the Internal Revenue Service, state and local tax authorities, and non-U.S. tax authorities—including those in Canada and the Philippines—if and when the attributes are utilized in a future period.
Following the acquisition, the Company transitioned its Canadian operations from a client-facing business to a cost center. A formal transfer pricing study between the U.S. and Canada has not been performed, and as such, there may be a potential for a Canadian tax liability. However, based on currently available information, management believes that any such liability would not be material to the financial statements as a whole.
NOTE 15 –Credit Risk and Concentrations
Financial instruments that subject the Company to credit risk consist principally of trade accounts receivable and cash and cash equivalents. The Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk. The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk of its customers, establishes an allowance for credit losses and, consequently, believes that its accounts receivable credit risk exposure beyond such allowances is limited.
The Company maintains cash deposits with financial institutions, which, from time to time, may exceed federally insured limits. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Cash is also maintained at foreign financial institutions for its Canadian and Philippines subsidiaries. Cash in foreign financial institutions as of December 31, 2024, was $166 thousand. Cash in foreign financial institutions as of December 31, 2023, was $300 thousand.
The Company has not experienced any losses and believes it is not exposed to any significant credit risk from cash. However, any loss incurred or lack of access to such funds could have a significant impact on the Company’s financial condition, results of operations, and cash flows.
Our top three customers accounted for approximately 24% and 22% of our gross revenue during the years ended December 31, 2024 and the period March 15, 2023 to December 31, 2023 (Successor). One customer accounted for 10% of our gross revenue in 2024, and a separate customer accounted for 12% of our gross revenue in 2023; however, each of these customers may or may not continue to be a significant contributor to revenue in 2023. The loss of a significant amount of business from one of our major customers would materially and adversely affect our results of operations until such time, if ever, as we are able to replace the lost business. Significant customers or projects in any one period may not continue to be significant customers or projects in other periods. To the extent that we are dependent on any single customer, we are subject to the risks faced by that customer to the extent that such risks impede the customer’s ability to stay in business and make timely payments to us.
Furthermore, as of December 31, 2024, the Company had a concentration of credit risk with respect to accounts receivable. Three customers represented a significant portion of the Company’s total outstanding accounts receivable balance. Three customers represented a approximately 82% of the Company’s total outstanding accounts receivable balance.
The Company continually monitors the creditworthiness of its customers and maintains an allowance for doubtful accounts based on historical experience and specific customer information. The Company does not require collateral from its customers. Management does not believe the concentration of credit risk represents a significant risk of loss based on current knowledge and collection history.
NOTE 16 –Segment Information
The Company has determined that it operates as a single operating segment. The Company offers a vertical software-as-a-service (or SaaS) platform for the enterprise. The flagship product, the CXAI Platform (pronounced “Sky”), provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The Company’s Chief Executive Officer is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on consolidated net income.
The CODM does not evaluate profitability below the level of the consolidated company. The Company uses net income (loss) as the primary measure of financial performance. However, in evaluating operating results on a budget versus actual basis, the Company focuses on cash-based operating expenses as a more cost of revenue, professional services, marketing, research and development, and other general and administrative expenses—to be significant. In contrast, the Company does not place significant emphasis on stock-based compensation, amortization of intangibles, change in fair value of warrant liabilities, loss on debt extinguishment, and other non-cash adjustments in its internal analysis of period-over-period operating results.
The following table presents selected financial information with respect to the Company’s single operating segment:
| Schedule of segment Information | |||
|---|---|---|---|
| Successor · Predecessor | |||
| (In thousands) | Year ended December 31, 2024 | Period fromMarch 15, 2023 toDecember 31,2023 | Period fromJanuary 1, 2023 toMarch 14,2023 |
| Revenue – Licenses | $6,202 | $4,560 | $1,204 |
| Revenue – Professional Services | 798 | 1,186 | 416 |
| Revenue – Hardware | 142 | - | - |
| Less: | |||
| Cost of revenue | 1,285 | 1,268 | 483 |
| Research and development | 5,744 | 5,309 | 1,455 |
| Sales and marketing | 2,870 | 3,242 | 964 |
| General and administrative | 5,489 | 4,294 | 2,293 |
| Other noncash expenses(1) | 5,495 | 39,841 | 806 |
| Interest expense (income), net | 1,756 | (65) | 1 |
| Loss on warrant liabilities | 3,152 | 4,714 | - |
| Loss on debt extinguishment | 1,052 | - | - |
| Other expense/(income), net | 342 | (47) | - |
| Add: | |||
| Income tax benefit | 635 | 3,572 | - |
| Net loss | $(19,408) | $(49,238) | $(4,380) |
| (1) | Other for the year ended December 31, 2024, includes $2.83 million of stock compensation and related expenses, $2.73 million of intangible amortization expense. Other for the period from March 15, 2023, to December 31, 2023 (Successor), includes $1.08 million of stock compensation expenses, $36.06 millions of goodwill impairment loss, 0.54 million of acquisition related cost, and $2.16 million of intangible amortization expense. |
NOTE 17 –Foreign Operations
The Company’s operations are located primarily in the United States, Canada, and the Philippines. Revenues by geographic area are attributed by country of domicile of the Company’s subsidiaries. The financial data by geographic area are as follows (in thousands):
| United States · Canada · Philippines · Eliminations · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| For the Year Ended December 31, 2024 (Successor) | ||||||||
| Revenues by geographic area | $6,729 | $413 | $917 | $(917) | $7,142 | |||
| Operating loss by geographic area | $(11,732) | $(2,054) | $45 | $ | - | $(13,741) | ||
| Net loss by geographic area | $(17,081) | $(2,368) | $41 | $ | - | $(19,408) | ||
| For the Period from March 15, 2023, to December 31, 2023 (Successor): | ||||||||
| Revenues by geographic area | $4,838 | $908 | $884 | $(884) | $5,746 | |||
| Operating income (loss) by geographic area | $(46,018) | $(2,380) | $190 | $ | - | $(48,208) | ||
| Net income (loss) by geographic area | $(47,073) | $(2,332) | $188 | $(21) | $(49,238) | |||
| For the Period from January 1, 2023, to March 14, 2023 (Predecessor): | ||||||||
| Revenues by geographic area | $1,395 | $285 | $160 | $(220) | $1,620 | |||
| Operating income (loss) by geographic area | $(3,479) | $(905) | $3 | $ | - | $(4,381) | ||
| Net income (loss) by geographic area | $(3,342) | $(1,041) | $3 | $ | - | $(4,380) | ||
| As of December 31, 2024 (Successor) | ||||||||
| Identifiable assets by geographic area | $31,087 | $272 | $444 | $ | - | $31,803 | ||
| Long lived assets by geographic area | $15,712 | $175 | $46 | $ | - | $15,933 | ||
| Goodwill by geographic area | $8,737 | $ | - | $ | - | $ | - | $8,737 |
| As of December 31, 2023 (Successor) | ||||||||
| Identifiable assets by geographic area | $38,143 | $627 | $434 | $(2,623) | $36,581 | |||
| Long lived assets by geographic area | $18,269 | $320 | $148 | $ | - | $18,737 | ||
| Goodwill by geographic area | $8,737 | $ | - | $ | - | $ | - | $8,737 |
NOTE 18 –Leases
The Company has operating leases for administrative offices in Canada, the Philippines, and the United States. The Manila, Philippines office lease expires in May 2025, the Canada lease expires in May 2026, and the United States office lease expires in April 2026. The Company has no other operating or financing leases with terms greater than 12 months.
Lease expense for operating leases recorded on the balance sheet is based on the future minimum lease payments recognized on a straight-line basis over the term of the lease plus any variable lease costs. Operating lease expenses, inclusive of short-term and variable lease expenses, recognized in the Company’s consolidated statement of operations for the year ended December 31, 2024 (Successor), for the period from March 15, 2023, to December 31, 2023 (Successor), and for the period from January 1, 2023 to March 14, 2023 (Predecessor) was approximately $439 thousand, $345 thousand, and $57 thousand, respectively.
Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the date of adoption of ASC 842 “Leases” (“ASC 842”). As of December 31, 2024, the weighted average remaining lease term is 1.1 years, and the weighted average discount rate used to determine the operating lease liabilities was 8.0%. As of December 31, 2023, the weighted average remaining lease term is 1.4 years, and the weighted average discount rate used to determine the operating lease liabilities was 8.0%.
| (in thousand) | OperatingLeases |
|---|---|
| Year 2025 | 376 |
| Year 2026 | 126 |
| Total lease payments | 502 |
| Less: Imputed interest | (29) |
| Present value of lease liabilities | $473 |
NOTE 19 –Commitments and Contingencies
Risks and Uncertainties
Various social and political circumstances in the United States and around the world (including wars and other forms of conflict, including trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic, tariffs, and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics) may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. In response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company and the value of the Company’s securities.
Management continues to evaluate the impact of these types of risks and has concluded that while it is reasonably possible that these risks and uncertainties could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Litigation
Certain conditions may exist as of the date the financial statements are issued which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed.
Loss contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed. There can be no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.
NOTE 20 –Supplementary Financial Information
Quarterly Financial Information (unaudited)—The quarterly results for the years ended December 31, 2024, and 2023 are summarized below (in thousands, except per share amounts):
| Successor | |||||
|---|---|---|---|---|---|
| 2024 | FourthQuarter | ThirdQuarter (restated) | SecondQuarter (restated) | FirstQuarter | Year Ended December 31, 2024 |
| Net Revenue | 1,661 | 1,897 | 1,766 | 1,818 | 7,142 |
| Gross Profit | 1,428 | 1,525 | 1,413 | 1,491 | 5,857 |
| Net Loss | (3,978) | (5,004) | (5,256) | (5,170) | (19,408) |
| Basic and diluted weighted average shares outstanding, Class A common stock | 17,234,557 | 15,699,685 | 15,255,218 | 15,254,389 | 15,907,946 |
| Basic and diluted net loss per share, Class A common stock | (0.23) | (0.32) | (0.36) | (0.34) | (1.22) |
| Basic and diluted weighted average shares outstanding, Class C common stock | - | - | - | - | - |
| Basic and diluted net income (loss) per share, Class C common stock | - | - | - | - | - |
| Successor · Predecessor | ||||||
|---|---|---|---|---|---|---|
| 2023 | FourthQuarter | ThirdQuarter | SecondQuarter | Period fromMarch 15, 2023 to March 31,2023 | Period fromJanuary 1, 2023, to March 14,2023 | Total |
| Net Revenue | 1,719 | 1,770 | 1,915 | 342 | 1,620 | 7,366 |
| Gross Profit | 1,376 | 1,412 | 1,435 | 255 | 1,137 | 5,615 |
| Net Income / (Loss) | (38,707) | 1,441 | (14,730) | 2,758 | (4,380) | (53,618) |
| Basic and diluted weighted average shares outstanding, Class A common stock | 15,254,389 | 10,818,459 | 8,582,699 | 8,582,699 | - | - |
| Basic and diluted net income (loss) per share, Class A common stock | (2.54) | 0.13 | (1.05) | 0.20 | - | - |
| Basic and diluted weighted average shares outstanding, Class C common stock | - | - | 5,487,300 | 5,487,300 | - | - |
| Basic and diluted net income (loss) per share, Class C common stock | - | - | (1.05) | 0.20 | - | - |
NOTE 21 –Restatement of Quarterly Financial Information (Unaudited)
As further described in Note 1, the previously reported unaudited consolidated financial information for the three and six months ended June 30, 2024, and the three and nine months ended September 30, 2024 are required to be restated. The as-restated interim financial information for each relevant period is included in the tables that follow. As part of the restatement, the Company recorded adjustments to correct the misstatements in the impacted interim periods.
Consolidated Balance Sheets
The following unaudited consolidated balance sheet tables present the impacts of the restatement adjustments as of the periods ended June 30, 2024, and September 30, 2024.
| Schedule of consolidated balance sheets | ||||
|---|---|---|---|---|
| (in thousands) · As Previously Reported · Adjustments to Debt · As Restated | ||||
| Contract to issue common stock | - | 130 | 130 | |
| Convertible debt | 2,493 | 82 | 2,575 | |
| Total Liabilities | $17,294 | $212 | $17,506 | |
| Stockholders’ Equity | ||||
| Accumulated deficit | (68,227) | (212) | (68,439) | |
| Total Stockholders’ Equity | $16,480 | $(212) | $16,268 | |
| Total Liabilities and Stockholders’ Equity | $33,774 | $ | - | $33,774 |
| (in thousands) · As Previously Reported · Adjustments to Debt · Adjustments to Accrued Legal Fees · As Restated | ||||||
|---|---|---|---|---|---|---|
| Accrued liabilities | 1,666 | - | 359 | 2,025 | ||
| Contract to issue common stock | - | 130 | - | 130 | ||
| Convertible debt | 3,539 | 153 | - | 3,692 | ||
| Total Liabilities | $17,300 | $283 | $359 | $17,942 | ||
| Stockholders’ Equity | ||||||
| Accumulated deficit | (73,231) | (283) | (359) | (73,873) | ||
| Total Stockholders’ Equity | $14,275 | $(283) | $(359) | $13,633 | ||
| Total Liabilities and Stockholders’ Equity | $31,575 | $ | - | $ | - | $31,575 |
Consolidated Statements of Operations and Comprehensive Loss
The following unaudited consolidated statements of operations and comprehensive loss tables present the impacts of the restatement adjustments for the three and six months ended June 30, 2024, and the three and nine months ended September 30, 2024.
| Schedule of consolidated statements of operations and comprehensive Loss | |||
|---|---|---|---|
| (in thousands) | As Previously Reported | Adjustments to Debt | As Restated |
| Interest income (expense), net | (684) | (262) | (946) |
| Change in fair value of derivative liability | (1,051) | 50 | (1,001) |
| Total Other Income (Expense) | (1,765) | (212) | (1,977) |
| Net Loss, before tax | (5,415) | (212) | (5,627) |
| Net Loss | $(5,256) | $(212) | $(5,468) |
| Comprehensive Loss | $(5,234) | $(212) | $(5,446) |
| Basic and diluted net loss per share, Class A common stock | $(0.34) | $(0.02) | $(0.36) |
| (in thousands) | As Previously Reported | Adjustments to Debt | As Restated |
|---|---|---|---|
| Interest income (expense), net | (946) | (262) | (1,208) |
| Change in fair value of derivative liability | (2,523) | 50 | (2,473) |
| Total Other Income (Expense) | (3,555) | (212) | (3,767) |
| Net Loss, before tax | (10,792) | (212) | (11,004) |
| Net Loss | $(10,426) | $(212) | $(10,638) |
| Comprehensive Loss | $(10,350) | $(212) | $(10,562) |
| Basic and diluted net loss per share, Class A common stock | $(0.68) | $(0.02) | $(0.70) |
| Three Months Ended September 30, 2024, | ||||||
|---|---|---|---|---|---|---|
| (in thousands) · As Previously Reported · Adjustments to Debt · Adjustments to Accrued Legal Fees · As Restated | ||||||
| General and administrative | 1,927 | - | 359 | 2,826 | ||
| Total Operating Expenses | $4,851 | $ | - | $359 | $2,826 | |
| Interest income (expense), net | (312) | (4) | - | (316) | ||
| Change in fair value of derivative liability | (1,052) | (67) | - | (1,119) | ||
| Total Other Income (Expense) | $(1,825) | $(71) | $ | - | $(1,896) | |
| Net Loss, before tax | (5,151) | (71) | (359) | (5,581) | ||
| Net Loss | $(5,004) | (71) | (359) | (5,434) | ||
| Comprehensive Loss | $(5,046) | $(71) | $(359) | $(5,476) | ||
| Basic and diluted net loss per share, Class A common stock | $(0.32) | $ | - | $(0.02) | $(0.34) | |
| Nine Months Ended September 30, 2024, | ||||||
|---|---|---|---|---|---|---|
| (in thousands) · As Previously Reported · Adjustments to Debt · Adjustments to Accrued Legal Fees · As Restated | ||||||
| General and administrative | 5,384 | - | 359 | 5,743 | ||
| Total Operating Expenses | $14,992 | $ | - | $359 | $15,351 | |
| Interest income (expense), net | (1,258) | (266) | - | (1,524) | ||
| Change in fair value of derivative liability | (3,575) | (17) | - | (3,592) | ||
| Total Other Income (Expense) | $(5,380) | $(283) | $ | - | $(5,663) | |
| Net Loss, before tax | (15,943) | (283) | (359) | (16,585) | ||
| Net Loss | $(15,430) | (283) | (359) | (16,072) | ||
| Comprehensive Loss | $(15,396) | $(283) | $(359) | $(16,038) | ||
| Basic and diluted net loss per share, Class A common stock | $(1.00) | $(0.02) | $(0.02) | $(1.04) | ||
Consolidated Statements of Stockholders’ Equity
The following unaudited consolidated statements of stockholders’ equity tables present the impacts of the restatement adjustments for the three months ended June 30, 2024, and September 30, 2024.
| Schedule of consolidated statements of stockholders’ equity | ||||
|---|---|---|---|---|
| Accumulated Deficit · Total Stockholders’ Equity (Deficit) | ||||
| As Previously Reported | ||||
| Balance at March 31, 2024 | $(62,971) | $20,881 | ||
| Net loss | (5,256) | (5,256) | ||
| Balance at June 30, 2024 | $(68,227) | $16,480 | ||
| Adjustments to Debt | ||||
| Balance at March 31, 2024 | $ | - | $ | - |
| Net loss | (212) | (212) | ||
| Balance at June 30, 2024 | $(212) | $(212) | ||
| As Restated | ||||
| Balance at March 31, 2024 | $(62,971) | $20,881 | ||
| Net loss | (5,468) | (5,468) | ||
| Balance at June 30, 2024 | $(68,439) | $16,268 | ||
| (in thousands) · Accumulated deficit · Total Stockholders’ Equity (Deficit) | ||||
|---|---|---|---|---|
| As Previously Reported | ||||
| Balance at March 31, 2024 | $(62,971) | $20,881 | ||
| Net loss | (5,256) | (5,256) | ||
| Balance at June 30, 2024 | $(68,227) | $16,480 | ||
| Net loss | (5,004) | (5,004) | ||
| Balance at September 30, 2024 | $(73,231) | $14,275 | ||
| Adjustments to Debt | ||||
| Balance at March 31, 2024 | $ | - | $ | - |
| Net loss | (212) | (212) | ||
| Balance at June 30, 2024 | $(212) | $(212) | ||
| Net loss | (71) | (71) | ||
| Balance at September 30, 2024 | $(283) | $(283) | ||
| Adjustments to Accrued Legal Fees | ||
|---|---|---|
| Balance at March 31, 2024 · $ · - · $ · - | ||
| Net loss | - | - |
| Balance at June 30, 2024 · $ · - · $ · - | ||
| Net loss | (359) | (359) |
| Balance at September 30, 2024 | $(359) | $(359) |
| As Restated | ||
| Balance at March 31, 2024 | $(62,971) | $20,881 |
| Net loss | (5,468) | (5,468) |
| Balance at June 30, 2024 | $(68,439) | $16,268 |
| Net loss | (5,434) | (5,434) |
| Balance at September 30, 2024 | $(73,873) | $13,633 |
Consolidated Statements of Cash Flows
The following unaudited consolidated statements of cash flow tables present the impacts of the restatement adjustments for the six months ended June 30, 2024, and the nine months ended September 30, 2024.
| Schedule of consolidated statements of cash flows | |||
|---|---|---|---|
| (in thousands) | As Previously Reported | Adjustments to Debt | As Restated |
| Operating activities | |||
| Net Loss | $(10,426) | $(212) | $(10,638) |
| Adjustments to reconcile net loss to net cash used in operating activities | |||
| Amortization of debt discount and deferred financing cost | 445 | 272 | 717 |
| Accrued interest expense on promissory note and convertible debt | 210 | (10) | 200 |
| Change in fair value of derivative liability | 2,523 | (50) | 2,473 |
| Net cash used in operating activities | (2,560) | - | (2,560) |
| Nine Months Ended September 30, 2024, | ||||
|---|---|---|---|---|
| (in thousands) | As Previously Reported | Adjustments to Debt | Adjustments to Accrued Legal Fees | As Restated |
| Operating activities | ||||
| Net loss | $(15,430) | $(283) | $(359) | $(16,072) |
| Change in operating assets and liabilities: | ||||
| Accrued liabilities | 214 | - | 359 | 573 |
| Adjustments to reconcile net loss to net cash used in operating activities | ||||
| Amortization of debt discount and deferred financing cost | 678 | 310 | - | 988 |
| Accrued interest expense on promissory note and convertible debt | 340 | (44) | - | 296 |
| Change in fair value of derivative liability | 3,575 | 17 | - | 3,592 |
| Net cash used in operating activities | (4,629) | - | - | (4,629) |
NOTE 22 –Subsequent Events
Note Exchanges
During the period from January 1, 2025, to January 29, 2025, the Company exchanged $605 thousand of the outstanding balance of the December 2023 Note for approximately 311,783 shares of the Company’s Class A Common Stock at exchange prices between $1.79 and $2.03 per share. The loss on the exchange is approximately $48 thousand.
Convertible Debt Conversion
In January 31, 2025, the Company has issued 242,491 shares of the Company’s Class A Common Stock related to Purchase Notice dated January 28, 2025, for an exchange amount of $297 thousand.
Securities Purchase Agreement with Avondale Capital, LLC
Securities Purchase Agreement with Avondale Capital
On March 26, 2025, the Company entered into a Securities Purchase Agreement (“SPA”) with Avondale Capital, LLC (“Investor”), pursuant to which the Company may issue and sell up to $20,000 thousand of Pre-Paid Purchase agreements (“Pre-Paid Purchases”) in tranches over time. The initial tranche included a $4,200 thousand Pre-Paid Purchase, structured with a $200 thousand original issue discount (“OID”) and $10 thousand in transaction-related fees, resulting in net proceeds of $4,000 thousand. In connection with the initial closing, the Company issued 80,000 commitment shares to the Investor.
Under the terms of the SPA, the Investor may, at its discretion and with approval of Management, convert outstanding balances into shares of the Company’s common stock at predefined fixed or formula-based prices. These conversion prices are subject to customary adjustments for stock splits, reverse splits, reclassifications, dilutive issuances, and similar corporate actions.
The agreement contains mandatory repayment provisions, including:
| ● | A Floor Price Trigger, requiring monthly cash repayments of $500 plus accrued interest if the Company’s volume-weighted average price (“VWAP”) remains below a specified Floor Price for 5 out of 7 consecutive trading days. |
| ● | An Exchange Cap Trigger, which obligates repayment if the Company reaches 90% of the maximum share issuance allowed under Nasdaq Listing Rule 5635(d), unless stockholder approval is obtained. |
Failure to meet these obligations or other covenant breaches would constitute an Event of Default, triggering immediate repayment of the outstanding balance plus a 10% penalty and default interest at 18% per annum.
For accounting purposes, the Pre-Paid Purchases are recorded as liabilities, due to the potential for cash settlement. The embedded conversion features and other repayment features, including the Beneficial Conversion Feature and variable-price reset mechanisms, are derivatives under ASC 815-15. The liability is remeasured each reporting period, with changes in fair value recognized in earnings.
The Company is required to maintain an effective registration statement (Form S-1) for the resale of shares issuable under the SPA and obtain stockholder approval by May 31, 2025, to issue shares beyond the Exchange Cap. Failure to obtain such approval would require the Company to settle all remaining obligations in cash.
These financing arrangements may impact the Company’s liquidity, shareholder dilution, and introduce non-cash earnings volatility related to periodic fair value adjustments of derivative instruments.
Additional Pre-Paid Purchases.
So long as certain conditions set forth in the Purchase Agreement are satisfied, including minimum trading volume thresholds and the receipt of shareholder approval to exceed applicable Nasdaq limitations, we may request one or more additional Pre-Paid Purchases. Each subsequent Pre-Paid Purchase will have (i) an original issue discount of five percent (5%) of the requested amount, (ii) no additional transaction expense beyond that initial $10,000.00, (iii) a floor price equal to 20% of the applicable Minimum Price, and (iv) a “fixed price” component capped at 120% of the Minimum Price on the closing day for such Pre-Paid Purchase. The Company retains the discretion to draw or to forego any Pre-Paid Purchases beyond the initial closing.
Nasdaq Listing Rule 5635(d) Limitation.
Notwithstanding anything to the contrary, unless and until the Company obtains requisite stockholder approval as required by Nasdaq Listing Rule 5635(d), the total cumulative number of shares of Common Stock that may be issued to Avondale under all Pre-Paid Purchases cannot exceed the numerical threshold required by that rule (the “Exchange Cap”). If we do not obtain such approval at our upcoming annual meeting or any adjournment or postponement thereof, any remaining outstanding balance above the Exchange Cap under any Pre-Paid Purchase must be satisfied in cash. The Purchase Agreement also contains standard beneficial ownership limitations preventing Avondale from exceeding 9.99% beneficial ownership of our outstanding Common Stock.
Registration Obligations.
The Company has agreed to file a registration statement covering the resale of at least 10,000,000 shares (including the Commitment Shares and those potentially issuable under the Initial Pre-Paid Purchase) within 30 days following the initial closing. Additional registration obligations may be triggered if the Company elects to draw any subsequent Pre-Paid Purchases, such that the full $20,000,000.00 of the Commitment Amount (including all shares issuable thereunder) is registered for resale. This summary specifically covers the Commitment Shares and the shares underlying the Initial Pre-Paid Purchase. Any subsequent Pre-Paid Purchase or shares issuable thereunder will be registered pursuant to new or amended registration statements if and when such Pre-Paid Purchases occur.
Use of Proceeds.
We intend to use the net proceeds from any Pre-Paid Purchases primarily for working capital and general corporate purposes, as detailed in the applicable registration statement and in accordance with the terms of the Purchase Agreement. The Company is not obligated to request any Pre-Paid Purchase beyond the initial one.
Potential Dilutive Effects.
Depending on market conditions and other factors, issuances of Common Stock under the Pre-Paid Purchases may result in substantial dilution to existing shareholders. The amount of dilution will depend on various factors, including the number of shares ultimately issued and the applicable Purchase Share Purchase Price at the time of each conversion.
No additional issuance of Common Stock under the Purchase Agreement would occur if it would exceed the Exchange Cap under Nasdaq Listing Rule 5635(d) absent the required stockholder approval. The Company has committed to seeking this approval on or before May 31, 2025, and if not obtained, it will continue seeking such approval every 90 days until the approval is secured, or the Pre-Paid Purchase outstanding balance is otherwise satisfied in accordance with the Purchase Agreement.
This description is qualified in its entirety by reference to the text of the Purchase Agreement, a copy of which is attached hereto as Exhibit 10.14 and also is incorporated herein by reference.
| (b) | Exhibits: The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Annual Report. |
| 2.1(1) | Agreement and Plan of Merger, dated as of September 25, 2022, by and among KINS Technology Group Inc., Inpixon, CXApp Holding Corp. and KINS Merger Sub Inc. |
| 2.2(1) | Separation and Distribution Agreement, dated as of September 25, 2022, by and among KINS Technology Group Inc., Inpixon, CXApp Holding Corp. and Design Reactor, Inc. |
| 2.3(1) | Sponsor Support Agreement, dated as of September 25, 2022, by and among KINS Capital LLC, KINS Technology Group Inc., Inpixon and CXApp Holding Corp. |
| 3.1(2) | Amended and Restated Certificate of Incorporation of the Company. |
| 3.2(2) | Amended and Restated Bylaws of the Company. |
| 4.1 | Warrant Agreement, dated as of December 14, 2020, by and between KINS and Continental Stock Transfer & Trust Company, as warrant agent (incorporated herein by reference from Exhibit 4.1 on KINS’ Form 8-K, filed December 21, 2020). |
| 4.2(2) | Specimen CXApp Inc. Class A Common Stock Certificate. |
| 4.3(2) | Specimen CXApp Inc. Class C Common Stock Certificate. |
| 4.4(2) | Specimen Warrant Certificate of the Company. |
| 4.5(*) | Description of the Company’s securities. |
| 10.1(2)(#) | Employee Matters Agreement, dated March 14, 2023, by and among KINS, KINS Merger Sub Inc., Inpixon, and Legacy CXApp. |
| 10.2(2) | Tax Matters Agreement, dated March 14, 2023, by and among KINS, Inpixon, and Legacy CXApp. |
| 10.3(2) | Transition Services Agreement, dated March 14, 2023, by and between Inpixon and Legacy CXApp. |
| 10.4(2)(#) | Consulting Agreement, dated March 14, 2023, by and between Design Reactor, Inc. and 3AM, LLC. |
| 10.5(#) | Employment Agreement, dated as of January 9, 2023, by and between Design Reactor, Inc. and Khurram Sheikh. (incorporated by reference to the Company’s Current Report on Form 8-K filed on March 31, 2023). |
| 10.6(#) | Offer Letter, dated as of July 18, 2024, by and between Joy Mbanugo and CXApp Inc. (incorporated by reference to the Company’s Current Report on Form 8-K filed on August 20, 2024). |
| 10.7(2)(#) | CXApp Inc. 2023 Equity Incentive Plan. |
| 10.8 | Securities Purchase Agreement, dated as of May 22, 2024, by and between CXApp Inc. and Streeterville Capital, LLC (incorporated herein by reference from Exhibit 10.8 on CXApp’s Form 10-K filed May 24, 2024). |
| 10.9(*) | Exchange Agreement, dated as of June 25, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.10(*) | Exchange Agreement, dated as of July 19, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.11(*) | Exchange Agreement, dated as of August 8, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.12(*) | Exchange Agreement, dated as of August 13, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.13(*) | Exchange Agreement, dated as of August 16, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.14(*) | Exchange Agreement, dated as of December 9, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.15(*) | Exchange Agreement, dated as of December 10, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.16(*) | Exchange Agreement, dated as of December 17, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.17(*) | Exchange Agreement, dated as of December 26, 2024, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.18(*) | Exchange Agreement, dated as of January 6, 2025, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.19(*) | Exchange Agreement, dated as of January 17, 2025, by and between CXApp Inc. and Streeterville Capital, LLC. |
| 10.20(*) | Securities Purchase Agreement, dated as of March 26, 2025, by and between CXApp Inc. and Avondale Capital, LLC |
| 14.01(2) | Code of Ethics and Business Conduct of CXApp Inc. |
| 19.1(*) | Insider Trading Policy. |
| 23.1(*) | Consent of Marcum LLP. |
|---|---|
| 23.2(*) | Consent of WithumSmith+Brown, PC. |
| 31.1(*) | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2(*) | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1(**) | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2(**) | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 97.1(*) | Clawback Policy. |
| 101.INS | XBRL Instance Document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
| * | Filed herewith. |
| ** | Furnished herewith. |
| (1) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on September 26, 2022. |
| (2) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on March 20, 2023. |
| # | Indicates a management contract or compensatory plan. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.